AR087811A1 - Vacuna contra el staphylococcus aureus - Google Patents
Vacuna contra el staphylococcus aureusInfo
- Publication number
- AR087811A1 AR087811A1 ARP120103309A ARP120103309A AR087811A1 AR 087811 A1 AR087811 A1 AR 087811A1 AR P120103309 A ARP120103309 A AR P120103309A AR P120103309 A ARP120103309 A AR P120103309A AR 087811 A1 AR087811 A1 AR 087811A1
- Authority
- AR
- Argentina
- Prior art keywords
- protein
- staphylococcus aureus
- vaccine against
- against staphylococcus
- ssl3
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 5
- 241000191967 Staphylococcus aureus Species 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 6
- 108090000623 proteins and genes Proteins 0.000 abstract 6
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Se refiere al campo de la vacunología, especialmente de vacunas contra Staphylococcus aureus, tanto para aplicación en seres humanos como en el campo veterinario. En particular, se refiere a una proteína similar al súper antígeno estafilocócico 3 (SSL3, por sus siglas en inglés), o su homólogo, o un fragmento inmunogénico de cualquier proteína, para su uso en una vacuna contra S. aureus. Del mismo modo, se refiere a vacunas, métodos y usos médicos de estas proteínas. Reivindicación 1: Una proteína similar al súper antígeno estafilocócico 3 (SSL3), o un homólogo de dicha proteína SSL3, o un fragmento inmunogénico de cualquier proteína, para su uso en una vacuna contra Staphylococcus aureus.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11180633 | 2011-09-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR087811A1 true AR087811A1 (es) | 2014-04-16 |
Family
ID=46851966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120103309A AR087811A1 (es) | 2011-09-08 | 2012-09-07 | Vacuna contra el staphylococcus aureus |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20140248273A1 (es) |
| AR (1) | AR087811A1 (es) |
| AU (1) | AU2012306282A1 (es) |
| WO (1) | WO2013034682A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015000022A1 (en) * | 2013-07-05 | 2015-01-08 | Adelaide Research & Innovation Pty Ltd | Treatment and prevention of mastitis |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| CN109942719A (zh) * | 2019-05-07 | 2019-06-28 | 中国人民解放军陆军军医大学第二附属医院 | 一种金黄色葡萄球菌融合蛋白及其蛋白表达载体和纯化方法 |
| SE2200142A1 (en) * | 2022-12-13 | 2024-06-14 | Savacc Ab | Chrisvacc |
| WO2025116751A1 (en) * | 2023-12-01 | 2025-06-05 | Auckland Uniservices Limited | Multivalent vaccine compositions |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
| NZ207394A (en) | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
| SE8405493D0 (sv) | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
| WO1986006487A1 (en) | 1985-04-22 | 1986-11-06 | Commonwealth Serum Laboratories Commission | Method for determining mimotopes |
| EP0382271B1 (en) | 1989-02-04 | 1994-12-21 | Akzo Nobel N.V. | Tocols as adjuvant in vaccine |
| FR2714074B1 (fr) | 1993-12-20 | 1996-03-01 | Pasteur Institut | Promoteurs des gènes GRA1, GRA2, GRA5 et GRA6 de toxoplasma gondii et vecteurs d'expression comprenant lesdits promoteurs. |
| IL120202A (en) | 1996-03-07 | 2001-03-19 | Akzo Nobel Nv | Container with freeze-dried vaccine components |
| GB0014907D0 (en) * | 2000-06-20 | 2000-08-09 | Univ Sheffield | Antigenic polypeptides |
| CN100421730C (zh) | 2002-07-10 | 2008-10-01 | 英特威国际有限公司 | 免疫原性组合物 |
| WO2005092918A2 (en) | 2004-03-22 | 2005-10-06 | University College London | Targeting polypeptide |
| US7838244B2 (en) * | 2004-03-24 | 2010-11-23 | Auckland Uniservices Limited | SET1 proteins and uses thereof |
| TWI398272B (zh) | 2005-03-08 | 2013-06-11 | Intervet Int Bv | 化學定義的安定劑 |
| WO2007118687A2 (en) * | 2006-04-13 | 2007-10-25 | Umc Utrecht Holding Bv | Use of staphylococcal superantigen-like protein 5 (ssl5) in medicine |
| US20110313137A1 (en) | 2009-02-25 | 2011-12-22 | Dongxing Zha | Her2 antibody compositions |
-
2012
- 2012-09-07 AU AU2012306282A patent/AU2012306282A1/en not_active Abandoned
- 2012-09-07 AR ARP120103309A patent/AR087811A1/es unknown
- 2012-09-07 US US14/343,079 patent/US20140248273A1/en not_active Abandoned
- 2012-09-07 WO PCT/EP2012/067500 patent/WO2013034682A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012306282A1 (en) | 2014-03-20 |
| US20140248273A1 (en) | 2014-09-04 |
| WO2013034682A1 (en) | 2013-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2018000320A1 (es) | Coadyuvantes basados en aceite (divisional de solicitud 201600650) | |
| MX395525B (es) | Composiciones inmunogenicas para usar en vacunas neumococicas. | |
| CO6640254A2 (es) | Método para preparar anticuerpos con propiedades mejoradas | |
| CY1119518T1 (el) | Τροποποιημενα αντιγονα φυματιωσης | |
| AR096113A1 (es) | Polipéptidos f de prefusión del virus sincicial respiratorio (rsv) solubles y estabilizados | |
| HUE059252T2 (hu) | Immunogén készítmények pneumokokkusz vakcinákban történõ alkalmazásra | |
| AR091316A1 (es) | Moleculas de union humanas que se pueden unir y neutralizar a los virus de la influenza b y sus usos | |
| MX2017015881A (es) | Formulaciones para vacunas contra la neoplasia y metodos para preparar las mismas. | |
| MX2019003004A (es) | Composiciones para inmunizacion contra staphylococcus aureus. | |
| AR089797A1 (es) | Vacunas contra clostridum difficile que comprenden toxinas recombinantes | |
| EA201891124A3 (ru) | Новые мукозные адъюванты и системы доставки | |
| MX2021006021A (es) | Procedimiento de disminucion de la inmunogenicidad de proteinas y peptidos. | |
| UA114286C2 (uk) | Спосіб лікування staphylococcus aureus | |
| MX381211B (es) | Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia. | |
| AR080313A1 (es) | Composiciones de virus de moquillo canino (cdv) recombinante y sus usos | |
| BR112018015367A2 (pt) | carreadores oromucosais de nanofibra para tratamento terapêutico | |
| AR087811A1 (es) | Vacuna contra el staphylococcus aureus | |
| JO3565B1 (ar) | الأجسام المضادة لشبيه الأنجيوبوييتين– 4 وطرق استخدامها | |
| DOP2014000140A (es) | Preparaciones que comprenden emodépsido amorfo | |
| MX2016000107A (es) | Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria. | |
| MX382924B (es) | Composición para prevenir infección por mycoplasma spp. | |
| BR112015023738B8 (pt) | Vacinas de nucleoproteina influenza | |
| MX2017013564A (es) | Formulaciones de glucopiranosil lipido a y alérgenos de cacahuete para administración sublingual. | |
| BR112012018840A2 (pt) | proteínas recombinantes para uso em vacina, anticorpos contra as ditas proteínas e métodos de diagnósticos e terapêuticos incluindo as mesmas | |
| BR112016012435A8 (pt) | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |